A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

Clinical trial NCT05731271 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05731271
Sponsor: Suzhou Transcenta Therapeutics Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Tumor Colorectal Adenocarcinoma

Start date: 2023-02-08
Primary completion: 2026-06-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.